Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Infinity Pharmaceuticals Inc INFIQ

Healthcare Biotechnology
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing medicines for people with cancer. The Company is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma (PI3K... see more

Recent & Breaking News (GREY:INFIQ)

Bristol-Myers Squibb and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Opdivo (nivolumab) in Combination with IPI-549 in Advanced Solid Tumors

Business Wire November 9, 2016

How These Biotech Stocks are Faring? -- Ocular Therapeutix, Idera Pharma, Conatus Pharma, and Infinity Pharma

PR Newswire November 4, 2016

Infinity Moves the Date of its Third Quarter 2016 Financial Results Conference Call and Webcast

PR Newswire November 4, 2016

Verastem Licenses Duvelisib from Infinity Pharmaceuticals

Business Wire November 2, 2016

Infinity Announces The Date Of Its Third Quarter 2016 Financial Results Conference Call And Webcast

PR Newswire October 31, 2016

Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

PR Newswire September 26, 2016

The Biggest Pharma Stock Blowups Of 2016

Benzinga.com  September 19, 2016

Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End Collaboration

PR Newswire June 28, 2016

Pre-market Equity Watch on Biotechnology -- Infinity Pharma, Nektar Therapeutics, Aralez Pharma, and BIND Therapeutics

PR Newswire June 23, 2016

Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle Pharmaceuticals, Inc., HCP, Inc., Immunomedics, Inc., Infinity Pharmaceuticals Inc., Neovasc, Inc., and Unilife Corporation

PR Newswire June 17, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Infinity Pharmaceuticals Inc. (INFI)

PR Newswire June 15, 2016

10 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  June 15, 2016

12 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  June 15, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Into Possible Securities Fraud Violations by Certain Officers and Directors of Infinity Pharmaceuticals, Inc.

Business Wire June 14, 2016

9 Biggest Mid-Day Losers For Tuesday

Benzinga.com  June 14, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Infinity Pharmaceuticals Inc. - INFI

PR Newswire June 14, 2016

Mid-Day Market Update: Yingli Green Energy Surges Following Q1 Earnings; Infinity Pharmaceuticals Shares Tumble

Benzinga.com  June 14, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  June 14, 2016

Mid-Morning Market Update: Markets Mostly Lower; Isle of Capri Casinos Profit Beats Views

Benzinga.com  June 14, 2016

12 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  June 14, 2016